Kantify joins Data-driven Advanced Therapeutics Accelerator

Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst
Mon 10 May 2021

We are proud to announce that Kantify has joined the Data-driven Advanced Therapeutics Accelerator, managed by Stevenage Bioscience Catalyst. The DATA Accelerator Programme is the first of its kind to focus on bringing together Artificial Intelligence and drug discovery, with a focal point on advanced therapeutics, genomics and data.

Kantify is dedicated to helping improve peoples’ lives through scientific innovations in the field of drug discovery. Joining the DATA Accelerator will help push forward the boundaries of our state-of-the-art AI technology for in silico high-throughput screening, by giving us access to plenty of exciting new resources.

Stevenage Bioscience Catalyst has formed a globally recognized cluster for therapeutics research and development, providing support for translation and commercialization of innovative new medicines.

Discover more about the DATA Accelerator Programme